Gene · 145624
PWAR1: Prader Willi/Angelman region RNA 1
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. PWAR1: Prader Willi/Angelman region RNA 1. Genes, record 145624. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/145624
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,042
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PWAR1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| R01HL049413 | Structural basis of prothrombin activation | 7 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P40OD018537 | Bloomington Drosophila Stock Center at Indiana University | 3 | 2025 |
| R01CA266339 | Maintaining the integrity of a genome | 3 | 2025 |
| R01DA012864 | Mechanisms and Cellular Function of Opioid Receptor Endocytosis | 3 | 2025 |
| R01HG002385 | Long-read sequence and assembly of segmental duplications | 3 | 2025 |
| R01HG010169 | Sequence resolution of complex human genome structural variation | 3 | 2025 |
| R01NS034783 | Function of NF2/Merlin in regulation of the Hippo/Salvador/Warts growth control pathway | 3 | 2025 |
1 to 10 of 1,042Source NIH's project files
See all 1,042 nih grantsPapers1,904
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-PAR2 autoantibodies are associated with chronic histological injury in kidney transplant recipients. | Front Immunol | 2026 | 42694230 | PubTator, text mining | PubMed |
| Pediatric B-Cell Acute Lymphoblastic Leukemia: Comprehensive Genomic Characterization Including SNP-Array and Analysis of Relapse Risk. | Cancers (Basel) | 2026 | 42649943 | PubTator, text mining | PubMed |
| Emerging roles of granzymes in neurodegeneration and neuroinflammation: mechanistic insights and therapeutic opportunities. | Acta Neuropathol | 2026 | 42611377 | PubTator, text mining | PubMed |
| Faecal proteases and immune signatures drive subtype-specific enteric neuronal activation in IBS. | Gut | 2026 | 42552107 | PubTator, text mining | PubMed |
| A Practical Approach to Platelet Phenotype Profiling Using Microplate Aggregometry. | Pharmaceuticals (Basel) | 2026 | 42356440 | PubTator, text mining | PubMed |
| Microparticles Released by Dengue Virus-Infected Monocytes Mediate Endothelial Activation and Vasculopathy. | Int J Mol Sci | 2026 | 42353087 | PubTator, text mining | PubMed |
| Platelet triggering receptor expressed on myeloid cells-like transcript 1 regulation in healthy donors and patients at risk of bleeding and thrombosis. | J Thromb Haemost | 2026 | 42297145 | PubTator, text mining | PubMed |
| Lymphatic endothelial cells actively shape immune responses in the lungs. | Curr Opin Immunol | 2026 | 42296935 | PubTator, text mining | PubMed |
| Combined optical genome mapping and cnv-seq identify complex Y-chromosome rearrangements and ectopy in 46,XX testicular disorder of sex development. | Mol Cytogenet | 2026 | 42289734 | PubTator, text mining | PubMed |
| Thrombin-PAR1 signaling regulates Topoisomerase 1 activity to bridge inflammation and breast cancer progression. | Cancer Lett | 2026 | 42219057 | PubTator, text mining | PubMed |
1 to 10 of 1,904
See all 1,904 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/145624
GET https://conductscience.org/api/genes/v1/145624/grants?page=2